Bifogade filer
Kurs
+2,19%
Likviditet
0,03 MEUR
Kalender
Tid* | ||
2025-08-06 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-06-04 | N/A | Årsstämma |
2025-02-12 | 08:30 | Bokslutskommuniké 2024 |
2024-08-07 | - | Kvartalsrapport 2024-Q2 |
2024-06-06 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2024-06-05 | - | Årsstämma |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-08-09 | - | Kvartalsrapport 2023-Q2 |
2023-06-15 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2023-06-14 | - | Årsstämma |
2023-03-22 | - | Bokslutskommuniké 2022 |
2022-08-10 | - | Kvartalsrapport 2022-Q2 |
2022-06-16 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2022-06-15 | - | Årsstämma |
2022-03-09 | - | Extra Bolagsstämma 2022 |
2022-02-16 | - | Bokslutskommuniké 2021 |
2021-08-11 | - | Kvartalsrapport 2021-Q2 |
2021-04-22 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2021-04-21 | - | Årsstämma |
2021-02-17 | - | Bokslutskommuniké 2020 |
2020-08-12 | - | Kvartalsrapport 2020-Q2 |
2020-04-23 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2020-04-22 | - | Årsstämma |
2020-02-19 | - | Bokslutskommuniké 2019 |
2019-08-14 | - | Kvartalsrapport 2019-Q2 |
2019-04-25 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2019-04-24 | - | Årsstämma |
2019-02-20 | - | Bokslutskommuniké 2018 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-08-16 | - | Extra Bolagsstämma 2018 |
2018-04-26 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2018-04-25 | - | Årsstämma |
2018-02-28 | - | Bokslutskommuniké 2017 |
2017-07-27 | - | Kvartalsrapport 2017-Q2 |
2017-04-27 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2017-04-26 | - | Årsstämma |
2017-02-02 | - | Bokslutskommuniké 2016 |
2016-10-20 | - | 15-10 2016-Q3 |
2016-08-10 | - | Kvartalsrapport 2016-Q2 |
2016-05-12 | - | Kvartalsrapport 2016-Q1 |
2016-04-26 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2016-04-25 | - | Årsstämma |
2016-02-25 | - | Bokslutskommuniké 2015 |
2015-10-22 | - | Kvartalsrapport 2015-Q3 |
2015-08-20 | - | Kvartalsrapport 2015-Q2 |
2015-05-07 | - | Kvartalsrapport 2015-Q1 |
2015-04-21 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2015-04-20 | - | Årsstämma |
2015-02-26 | - | Bokslutskommuniké 2014 |
2014-10-23 | - | Kvartalsrapport 2014-Q3 |
2014-08-21 | - | Kvartalsrapport 2014-Q2 |
2014-05-08 | - | Kvartalsrapport 2014-Q1 |
2014-04-15 | - | X-dag ordinarie utdelning BIOBV 0.72 EUR |
2014-04-14 | - | Årsstämma |
2014-02-27 | - | Bokslutskommuniké 2013 |
2013-10-24 | - | Kvartalsrapport 2013-Q3 |
2013-08-08 | - | Kvartalsrapport 2013-Q2 |
2013-04-25 | - | Kvartalsrapport 2013-Q1 |
2013-04-09 | - | X-dag ordinarie utdelning BIOBV 0.50 EUR |
2013-04-08 | - | Årsstämma |
2013-02-27 | - | Bokslutskommuniké 2012 |
2012-10-25 | - | Kvartalsrapport 2012-Q3 |
2012-08-16 | - | Kvartalsrapport 2012-Q2 |
2012-04-26 | - | Kvartalsrapport 2012-Q1 |
2012-04-12 | - | X-dag ordinarie utdelning BIOBV 1.00 EUR |
2012-04-11 | - | Årsstämma |
2012-02-29 | - | Bokslutskommuniké 2011 |
2011-11-23 | - | Extra Bolagsstämma 2011 |
2011-10-20 | - | Kvartalsrapport 2011-Q3 |
2011-08-18 | - | Kvartalsrapport 2011-Q2 |
2011-04-28 | - | Kvartalsrapport 2011-Q1 |
2011-04-14 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2011-04-13 | - | Årsstämma |
2011-03-01 | - | Bokslutskommuniké 2010 |
2010-04-26 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2009-04-21 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2008-04-22 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2007-04-20 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2006-04-21 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2005-04-22 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2004-04-16 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2003-04-10 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2002-04-02 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2001-03-28 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
2000-04-07 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
1999-04-22 | - | X-dag ordinarie utdelning BIOBV 0.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Small Cap Helsinki |
Sektor | Hälsovård |
Industri | Medicinteknik |
Biohit Oyj will release its financial statements for 2021 on Wednesday 16[th] of February 2022 at 9:30 am.
The Annual Report, which contains the Financial Statements for 2021 and the Report of the Board of Directors, will be published on Wednesday 30[th] of March 2022 at 9:30.
Biohit Oyj's Annual General Meeting has been planned for Wednesday 15[th] of June 2022 at 2:00 pm. The Board of Directors will call the General Meeting at a later date.
Half year financial report for period January-June (H1) 2022 will be published on Wednesday 10[th] of August 2022 at 9:30 am.
The published economic reports and other stock exchange releases are available on Biohit's website at www.biohithealthcare.com/investors (https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.biohithealthcare.com%2Finvestors&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=7uDFWWvj4lup7uSXXVeo7EDJ4c71OBR%2FIVMnjPOA%2BWg%3D&reserved=0). The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases-to-your-email (https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.biohithealthcare.com%2Finvestors%2Fstock-exchange-releases%2Forder-releases-to-your-email&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=T9Onb0KniS%2Flhg6rgsFua6748gimIaDtPmi%2BeUkknHU%3D&reserved=0).
Additional information:
CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.biohithealthcare.com%2F&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=GgUivFiD2ZOAtSif14toy%2Fyj%2FqHKdd1Vm2vTRJ40I4E%3D&reserved=0)
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com (https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.biohithealthcare.com%2F&data=04%7C01%7CSanna.Kurlin%40biohit.fi%7Ce79379bd970246069f0608d9d50d0c93%7C4da67d2fc92245f9b72584364b1decf5%7C0%7C0%7C637775074284926203%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&sdata=GgUivFiD2ZOAtSif14toy%2Fyj%2FqHKdd1Vm2vTRJ40I4E%3D&reserved=0)